(Q43205090)

English

Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma

scientific article published in February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Steven Z. Pavletic

6

object named as

Steven Z Pavletic

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

author name string

Michael R Bishop

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

Robert M Dean

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

Seth M Steinberg

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

Jeanne Odom

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

Seth M Pollack

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

Claude Sportes

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

Ronald E Gress

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

Daniel H Fowler

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

language of work or name

0 references

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

116

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

852-862

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24845

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic graft-versus-host disease: clinical manifestation and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-myeloablative transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The graft-versus-lymphoma effect: fact, fiction, or opportunity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease as the target for immunotherapy and gene therapy of cancer (review).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic cell-mediated immunotherapy at the stage of minimal residual disease following high-dose chemotherapy supported by autologous stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report on the ISBTC mini-symposium on biologic effects of targeted therapeutics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Less yin, more yang: confronting the barriers to cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic transplantation in lymphoma: current status

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Passive, adoptive, and active immunotherapy: a review of clinical trials in cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation for low-grade lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24845

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24845

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6582966&resulttype=core&format=json

15 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43205090&oldid=1983696762"